| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/27/2004 | WO2004044160A2 Muc1 interference rna compositions and methods derived therefrom |
| 05/27/2004 | WO2004044156A2 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/27/2004 | WO2004044005A1 Kit for assaying human low-molecular weight cd14 and antibody |
| 05/27/2004 | WO2004044001A2 Acetylated hmgb1 protein |
| 05/27/2004 | WO2004043989A2 Human monoclonal antibodies to heparanase |
| 05/27/2004 | WO2004043988A2 Ptprk immunogenic peptide |
| 05/27/2004 | WO2004043563A2 Methods of isolation of active compounds and activated targets |
| 05/27/2004 | WO2004043487A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 05/27/2004 | WO2004043405A2 Polysaccharide vaccine for staphylococcal infections |
| 05/27/2004 | WO2004043376A2 Compositions and methods for treating or preventing pneumococcal infection |
| 05/27/2004 | WO2004043353A2 Compositions and methods for treating acute myeloid leukemia |
| 05/27/2004 | WO2004043344A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | WO2004043340A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 05/27/2004 | WO2004043332A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | WO2004043239A2 Antigen pipa and antibodies that bind thereto |
| 05/27/2004 | WO2004043238A2 Biomarkers for intra-amniotic inflammation |
| 05/27/2004 | WO2004043233A2 Assay for autoantibodies to folate receptors |
| 05/27/2004 | WO2004031239A3 Metastasis inducing compounds |
| 05/27/2004 | WO2004028259A3 A method for stabilizing bioactive molecules |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2004007520A3 Methods and compositions for preventing oxidative degradation of proteins |
| 05/27/2004 | WO2004005890A3 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 05/27/2004 | WO2004001655A8 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 05/27/2004 | WO2003085123A8 Methods anc compositions for in vivo clearance of pathogens |
| 05/27/2004 | WO2003068820A9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 05/27/2004 | WO2003054550A3 Uses of an endothelial cell receptor |
| 05/27/2004 | WO2003046567A3 Protein biopolymer markers predictive of alzheimers disease |
| 05/27/2004 | WO2003034977A3 Combination therapy for treating disease |
| 05/27/2004 | WO2003019142A9 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 05/27/2004 | WO2003015705A3 In situ immunization |
| 05/27/2004 | WO2003008541A8 Extracellular junctional adhesion molecules |
| 05/27/2004 | WO2002102985B1 Pate, a gene expressed in prostate cancer, prostate and testis, and uses thereof |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | WO2002043478A8 Transgenic transchromosomal rodents for making human antibodies |
| 05/27/2004 | WO2001066563A3 T1r taste receptors and genes encoding same |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | WO1999042077A3 Compositions and methods for regulating lymphocyte activation |
| 05/27/2004 | US20040102610 For diagnosis of cell proliferation/differentiation disorders of hedgehog (Hh) cascade signaling sequences |
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102407 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040102373 Protein-induced morphogenesis |
| 05/27/2004 | US20040102372 Therapeutic antiangiogenic compositions and methods |
| 05/27/2004 | US20040101940 Identification of a new cytotoxic activity from the ink of aplysia punctata |
| 05/27/2004 | US20040101939 Using maleuric acidic addition to decrease changes to immunoglobulins produced in milk of trangenic goats |
| 05/27/2004 | US20040101931 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 05/27/2004 | US20040101929 Comprises transgenic yellow grouper brain cell expressing immunoglobulin complex which prevents viral infection in teleost farms; animal husbandry and veterinary medicine |
| 05/27/2004 | US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections |
| 05/27/2004 | US20040101915 Diagnosis and treatment of chemoresistant tumors |
| 05/27/2004 | US20040101914 Immunglobulin capable of binding human single-chain intact prostate specific antigen (SCINT) for use in diagnosis of cancer |
| 05/27/2004 | US20040101913 Using immunoglobulin transferase binding activity to diagnose cancer |
| 05/27/2004 | US20040101911 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/27/2004 | US20040101910 Immunoglobulin capable of binding lymphocyte polypeptides for treatment and prevention of cell proliferative disorders; antitumor agents |
| 05/27/2004 | US20040101909 Purification of polyreactive autoantibodies and uses thereof |
| 05/27/2004 | US20040101905 Genetically engineered immunoglobulin comprising effector peptide binding site for use in immunodiagnostic imaging |
| 05/27/2004 | US20040101904 Delivery of pharmaceutical agents via the human insulin receptor |
| 05/27/2004 | US20040101899 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | US20040101833 Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and riluzole |
| 05/27/2004 | US20040101831 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 05/27/2004 | US20040101829 Protein that interacts with lipids and methods for treating hyperlipidemia |
| 05/27/2004 | US20040101536 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/27/2004 | US20040101530 Separation of anticancer antibodies using cancer cell cytotoxicity; complexing antibodies; medical diagnosis |
| 05/27/2004 | US20040101527 Complexing monoclonal antibodies with antigens; removal leukocytes; restenosis therapy; antiproliferative agents |
| 05/27/2004 | US20040101526 Bonding integrins and thrombospondin; artificial skin |
| 05/27/2004 | CA2757475A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2506091A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 05/27/2004 | CA2505974A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | CA2505932A1 Antimicrobial activity of antibodies producing reactive oxygen species |
| 05/27/2004 | CA2505931A1 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | CA2505924A1 Method for identifying antigen specific b cells |
| 05/27/2004 | CA2505633A1 Antigen pipa and antibodies that bind thereto |
| 05/27/2004 | CA2505537A1 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | CA2505250A1 Acetylated hmgb1 protein |
| 05/27/2004 | CA2505125A1 Assay for autoantibodies to folate receptors |
| 05/27/2004 | CA2504818A1 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | CA2503787A1 Methods of isolation of active compounds and activated targets |
| 05/27/2004 | CA2503303A1 Flavivirus fusion inhibitors |
| 05/27/2004 | CA2502490A1 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/27/2004 | CA2501077A1 Polysaccharide vaccine for staphylococcal infections |
| 05/26/2004 | EP1422527A1 Glycine N-methyltransferase monoclonal antibodies and methods of use therefore in the detection of cancer |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1422243A1 HUMANIZED ANTIBODY AGAINST FIBROBLAST GROWTH FACTOR−8 AND FRAGMENT OF THE ANTIBODY |
| 05/26/2004 | EP1422241A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421224A2 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421193A2 Novel metabolism-associated gene products of ashbya gossypii |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421118A1 A method for the treatment or prevention of bone erosion |
| 05/26/2004 | EP1421117A2 Compositions and methods for generating chimeric heteromultimers |
| 05/26/2004 | EP1421116A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases |
| 05/26/2004 | EP1421113A1 Methods of screening based on the egf receptor crystal structure |
| 05/26/2004 | EP1421112A1 Novel serine protease |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |